Avenir Wellness Solutions Inc (AVRW)

[ProfitScout]

The latest news from CURR this week on the award of the patent for demonstrates the very high marketing potential in the company's products for a range of important medical applications today. The ED products market should be especially lucrative.

Note management's comments:

OXNARD, Calif., March 17, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced the allowance of Chinese Patent No. ZL201480039313.6. The new patent covers the loading of high amounts of active drug on an oral thin film using its proprietary drug delivery systems, including its lead drug product, CUREfilm Blue™, a soluble thin film for oral administration of sildenafil citrate (Viagra™) to treat erectile dysfunction (ED) in China.

“Securing this key patent supports our global commercialization strategy for CUREfilm Blue as well as follow-on drugs delivered using thin film,” said Rob Davidson, CEO of CURE Pharmaceutical. “We are focused on the Asian market for this first product, and in particular China, a high-demand ED drug market where consumers are early adopters of innovative dosage forms.”